Qure.ai teams up with PATH India to improve COVID-19 and TB screening

14 September 2023 | News

To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding

image credit- shutterstock

image credit- shutterstock

Artificial intelligence (AI) firm, Qure.ai, is supporting PATH India to initiate an innovative project to overhaul tuberculosis (TB) and COVID-19 screening in Maharashtra through Unitaid funding. This strategic collaboration is centered on deploying the AI-powered qXR software, which will enhance the ability to analyse chest X-rays and substantially improve COVID-19 and TB screening at chosen implementation sites. Hosted on a cloud-based platform, the software ensures unfettered connectivity between different locations. 

Before the Unitaid grant, Mumbai-based startup Qure.ai's qXR was already operational in 7 Brihanmumbai Mahanagar Pallika Hospitals, where it was utilised to screen 90,000 plus patients for tuberculosis and other chest abnormalities. Remarkably, its implementation resulted in a 35% rise in TB notifications. This is attributed to the system's capability to identify patients who visited for reasons unrelated to TB, revealing incidental findings through the non-tuberculosis pathway.

Under the Unitaid-funded project, within a 12-month period, qXR is scheduled for deployment at four key medical facilities across Maharashtra. These include Dr. Zakir Hussain Hospital in Kathada and Hindu Hriday Samrat Balasaheb Thackrey Rugnalaya under the purview of the Nashik Municipal Corporation, as well as K.B Bhabha Hospital in Bandra which falls under the jurisdiction of the Municipal Corporation of Greater Mumbai. 

As a part of this project, patients will undergo AI-enabled chest X-ray screening for tuberculosis in the usual hospital workflow. Patients will commence their journey at the outpatient department (OPD), where an OPD doctor will perform initial screenings. Should it be deemed necessary, a chest X-ray will be carried out by an X-ray technician for patients suspected of having TB or chest infection. Patients will be directed to the TB counter for sputum collection when TB is suspected based on X-ray outcomes. This will be followed by CB-NAAT testing or AFB microscopy, ultimately leading to the commencement of treatment. 


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account